Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.
Perusini MA, Zackova D PhD, Kim T, Pagnano KBB, Pavlovsky C, Jeziskova I, Kvetková A, Jurcek T, Kim JJ, Yoo YS, Yi S, Lee H, Kim KH, Chang M, Capo-Chichi JM, Medeiros J, Arruda A, Minden MD, Zhang Z, Abelson S Dr, Mayer J, Kim DDH.
Perusini MA, et al. Among authors: arruda a.
Blood Adv. 2024 Mar 6:bloodadvances.2023012127. doi: 10.1182/bloodadvances.2023012127. Online ahead of print.
Blood Adv. 2024.
PMID: 38447114